Literature DB >> 15663966

Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy.

Masataka Nishimura1, Sadako Kuno, Ryuji Kaji, Hideshi Kawakami.   

Abstract

We studied promoter region polymorphisms in the tumor necrosis factor (TNF), interleukin (IL)-6, IL-10, and transforming growth factor (TGF)-beta1 genes in Japanese patients with multiple system atrophy (MSA) (n=122) and normal controls (n=277). The frequency of the TNF-1031C, a high producer allele of TNF, was increased significantly in MSA patients compared with controls (chi2=12.36, P=0.0021, Pc=0.0084). In contrast, there was no difference in the genotype or allele frequency in the other cytokine gene polymorphisms. We also failed to detect any difference in the disease onset between each genotype of the polymorphisms examined. Our findings suggest that TNF might have a toxic effect in MSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15663966     DOI: 10.1016/j.neulet.2004.10.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

2.  Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature.

Authors:  QuanZhen Zhao; Xinglong Yang; SiJia Tian; Ran An; JinHua Zheng; Yanming Xu
Journal:  Neurol Sci       Date:  2015-11-21       Impact factor: 3.307

Review 3.  Epidemiological evidence on multiple system atrophy.

Authors:  N Vanacore
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

4.  SHC2 gene copy number in multiple system atrophy (MSA).

Authors:  Marcus C Ferguson; Emily M Garland; Lora Hedges; Bethany Womack-Nunley; Rizwan Hamid; John A Phillips; Cyndya A Shibao; Satish R Raj; Italo Biaggioni; David Robertson
Journal:  Clin Auton Res       Date:  2013-10-30       Impact factor: 4.435

5.  Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.

Authors:  Elvira Valera; Kiren Ubhi; Michael Mante; Edward Rockenstein; Eliezer Masliah
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

6.  Genetic players in multiple system atrophy: unfolding the nature of the beast.

Authors:  Sylvia Stemberger; Sonja W Scholz; Andrew B Singleton; Gregor K Wenning
Journal:  Neurobiol Aging       Date:  2011-05-24       Impact factor: 4.673

7.  PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease.

Authors:  Cyndya Shibao; Emily M Garland; Alfredo Gamboa; Cindy L Vnencak-Jones; M Van Woeltz; Jonathan L Haines; Chang Yu; Italo Biaggioni
Journal:  Clin Auton Res       Date:  2008-01-30       Impact factor: 4.435

Review 8.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

9.  Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy.

Authors:  Eli Kaufman; Sara Hall; Yulia Surova; Håkan Widner; Oskar Hansson; Daniel Lindqvist
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 10.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.